Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
2.27% $9.96
America/New_York / 14 feb 2023 @ 15:59
FUNDAMENTALS | |
---|---|
MarketCap: | 364.37 mill |
EPS: | 0 |
P/E: | 0 |
Earnings Date: | N/A |
SharesOutstanding: | 36.58 mill |
Avg Daily Volume: | 0.181 mill |
RATING 2023-03-30 |
---|
B- |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Buy | |
Return On Asset: | Neutral | |
DE: | Sell | |
P/E: | Strong Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | ||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE -25.74 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 9.93 - 9.99 ( +/- 0.26%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-02 | Kathuria Chirinjeev | Sell | 500 000 | Common Stock, par value $0.0001 |
2023-03-22 | Ajjarapu Surendra K | Sell | 1 050 000 | Common Stock, par value $0.0001 |
2023-02-28 | Ajjarapu Surendra K | Buy | 21 252 | Common Stock, par value $0.0001 |
2023-02-14 | Ajjarapu Surendra K | Buy | 5 411 000 | Private Placement Warrant |
2023-02-14 | Ajjarapu Surendra K | Buy | 5 411 000 | Private Placement Warrant |
INSIDER POWER |
---|
19.04 |
Last 37 transactions |
Buy: 90 275 554 | Sell: 61 126 686 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $9.96 (2.27% ) |
Volume | 1.291 mill |
Avg. Vol. | 0.181 mill |
% of Avg. Vol | 715.01 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the pharmaceutical and medical devices sectors. The company was incorporated in 2021 and is based in New York, New York.